Back to Search
ANDY LIU, P. D
P. D
Pharmacist
NPI: 1851700504Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
22686(MD)
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (6)
Treatment Benefit with Omalizumab in Children by Indicators of Asthma Severity.
PMID 32298853·J Allergy Clin Immunol Pract·2020
8-other
Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children.
PMID 21410369·N Engl J Med·2011
4-observational
Prevalence of asthma and asthma-like symptoms in inner-city schoolchildren.
PMID 15801322·J Asthma·2005
8-other
Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
PMID 15180756·Allergy·2004
3-trial
Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma.
PMID 11496232·J Allergy Clin Immunol·2001
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3201 TIOGA PKWY, T-2393
BALTIMORE, MD 21215 - Phone
- (410) 369-1008
Quick Facts
- NPI
- 1851700504
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Clinical Trials
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile